glutathione s-transferase uniprot Information on EC 2.5.1.18 - transferase and Organism(s) Homo sapiens and Accession O15217 as well as in their non Glutathione transferases as mediators of

Stronger ones need a prescription

Imai and Guarente, 2014), an aspect that could worsen in these diseases because of its progressive nature ( + levels have been shown to decrease with age, leading to low levels in the brain (Zhu et al., 2015)

MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited published safety data Reported well-tolerated in small Russian studies Known interactions GABAergic medications (theoretical unstudied) Benzodiazepines (theoretical additive sedation) Contraindications Pregnancy/lactation (unstudied) Hypersensitivity REGULATORY STATUS FDA Not FDA-approved

Conclusion: Prior use of bile acid binding resins was low in the GLISTEN population despite its first-line position in treatment guidelines

Bignon M, et al